Caxton Corp as of Sept. 30, 2022
Portfolio Holdings for Caxton Corp
Caxton Corp holds 17 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Sts Oil Units Call Option (USO) | 21.3 | $11M | 174k | 65.28 | |
| Savara (SVRA) | 20.1 | $11M | 6.9M | 1.55 | |
| Xeris Pharmaceuticals (XERS) | 17.7 | $9.4M | 6.0M | 1.56 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 10.7 | $5.7M | 16k | 357.18 | |
| Scynexis Com New (SCYX) | 7.8 | $4.1M | 1.7M | 2.40 | |
| Rezolute Com New (RZLT) | 7.2 | $3.8M | 1.4M | 2.74 | |
| Spdr Ser Tr S&p Oilgas Exp (XOP) | 4.1 | $2.2M | 18k | 124.74 | |
| Molecular Templates | 2.9 | $1.5M | 2.1M | 0.75 | |
| Arcellx Common Stock (ACLX) | 2.7 | $1.4M | 76k | 18.77 | |
| Alps Etf Tr Alerian Mlp (AMLP) | 2.0 | $1.1M | 30k | 36.58 | |
| Eiger Biopharmaceuticals | 1.7 | $880k | 117k | 7.53 | |
| Vectivbio Hldg Ord Shs | 1.6 | $845k | 141k | 6.00 | |
| Elevation Oncology (ELEV) | 0.1 | $77k | 68k | 1.13 | |
| Frazier Lifesciences Acqu *w Exp 11/30/202 | 0.0 | $17k | 21k | 0.80 | |
| Lux Health Tech Acquisition *w Exp 11/30/202 | 0.0 | $9.0k | 67k | 0.14 | |
| Bridgetown Holdings *w Exp 09/30/202 | 0.0 | $5.0k | 40k | 0.13 | |
| Primavera Capital Acquist *w Exp 01/19/202 | 0.0 | $2.0k | 12k | 0.17 |
